Home | European Respiratory Society

Chronic cough
Read the articles from our call for papers on chronic cough as the final versions are published
Inhaled alkaline hypertonic divalent salts reduce refractory chronic cough frequency
Inhaled alkaline hypertonic divalent salt aerosol reduces cough frequency in refractory chronic cough patients with baseline cough rates in range 4–34 per h with highest control-adjusted efficacy (35% reduction) for pH 9 aerosol from 3 days post-dosing.
Assessing post-COVID-19 respiratory dynamics: a comprehensive analysis of pulmonary function, bronchial hyperresponsiveness and bronchodilator response
This study reveals post-COVID-19 patients often face AHR, with worsened respiratory symptoms like cough and dyspnoea. Methacholine tests are essential for diagnosis and tailoring treatments, emphasising the need for targeted post-COVID-19 care.
Development and validation of a machine learning-based model for post-sepsis frailty
A model that predicts post-sepsis frailty with high performance was developed using only 10 variables routinely assessed in daily practice. It also performed considerably well in an independent external data set composed of severe COVID-19 patients.
Corticosteroid therapy in fibrotic interstitial lung disease: a modified Delphi survey
The use of steroids in fibrotic interstitial lung diseases is founded on limited evidence. This modified Delphi survey sheds light on current clinical practices. Given the risks of steroids, clinical trials are needed to evaluate efficacy and harm.

Latest Articles

Efficacy of surveillance bronchoscopy versus clinically indicated bronchoscopy for detection of acute lung transplant rejection: a systematic review and meta-analysis
Kai Fricke, Noriane Andrina Sievi, Felix Peter Schmidt, Macé Matthew Schuurmans, Malcolm Kohler

ERJ Open Research Sep 2024, 10 (5) 00404-2024; DOI: 10.1183/23120541.00404-2024
Corticosteroid therapy in fibrotic interstitial lung disease: a modified Delphi survey
Manuela Funke-Chambour, Philipp Suter, Gisli R. Jenkins, Leticia Kawano-Dourado, Christopher J. Ryerson, Athol U. Wells, Michael Kreuter, Kerri A. Johannson, the Delphi Survey Participants

ERJ Open Research Sep 2024, 10 (5) 00561-2024; DOI: 10.1183/23120541.00561-2024
A new phenotype of patients with post-COVID-19 condition is characterised by a pattern of complex ventilatory dysfunction, neuromuscular disturbance and fatigue symptoms
Fridolin Steinbeis, Claudia Kedor, Hans-Jakob Meyer, Charlotte Thibeault, Mirja Mittermaier, Philipp Knape, Katharina Ahrens, Gabriele Rotter, Bettina Temmesfeld-Wollbrück, Leif Erik Sander, Florian Kurth, Martin Witzenrath, Carmen Scheibenbogen, Thomas Zoller

ERJ Open Research Sep 2024, 10 (5) 01027-2023; DOI: 10.1183/23120541.01027-2023
Slamf7 is dispensable in mouse models of acute lung injury
Emily M. King, Jazalle McClendon, Thienthanh Trinh, Jennifer L. Matsuda, Katelyn H. Lyn-Kew, Alexandra L. McCubbrey, Kara J. Mould, Peter M. Henson, William J. Janssen

ERJ Open Research Sep 2024, 10 (5) 00345-2024; DOI: 10.1183/23120541.00345-2024
Inhaled alkaline hypertonic divalent salts reduce refractory chronic cough frequency
Hisham Abubakar-Waziri, David A. Edwards, Deen Bhandu Bhatta, James H. Hull, Matthew Rudd, Peter Small, Kian Fan Chung

ERJ Open Research Sep 2024, 10 (5) 00241-2024; DOI: 10.1183/23120541.00241-2024
Cognitive interference of respiratory versus limb muscle dual tasking in healthy adults
Peter Rassam, Tamires de Mori, Marine Van Hollebeke, Dmitry Rozenberg, Paul Davenport, Lori Ann Vallis, W. Darlene Reid

ERJ Open Research Sep 2024, 10 (5) 00169-2024; DOI: 10.1183/23120541.00169-2024

About ERJ Open Research

ERJ Open Research is a fully open access original research journal, published online by the European Respiratory Society. The journal aims to publish high-quality work in all fields of respiratory science and medicine, covering basic science, clinical translational science and clinical medicine. It has a Journal Impact Factor of 4.3.

Tweets by @ERSpublications